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ABSTRACT 4 
Objectives: The study aimed to estimate the incidence and prevalence of feline lymphoma 5 
in cats attending primary-care practices across the UK and to identify patient-based and 6 
environmental (radon and pesticide exposure) risk factors. 7 
Materials and methods: Case records from the VetCompassTM programme from primary-8 
care veterinary practices in the UK were searched for a diagnosis of lymphoma in cats in 9 
2016. Cases were required to have had an external laboratory confirmed diagnosis based on 10 
cytology and/or histopathology. A nested case-control study design was used to identify risk 11 
factors for lymphoma using multivariable logistic regression. 12 
Results: From a cohort of 562,446 cats under veterinary care at VetCompass participating 13 
practices in 2016, a total of 271 lymphoma cases were identified (prevalence: 48/100,000, 14 
95% CI 44- 56/100,000; incidence 32/100,000, 95% CI 26- 35/100,000). There was 180 15 
incident lymphoma cases and 803 controls, all aged 2 years and older. Male (OR 1.7, 95% CI 16 
1.2-2.4, P=0.004), insured (OR 3.6, 95% CI 2.3-5.6, P=<0.001) and older cats (compared to 17 
cats 2 to <5 years, OR 5.0, 95% CI 2.8- 8.8, P=<0.001) were associated with increased odds of 18 
lymphoma diagnosis. Vaccinated cats were associated with decreased odds (OR 0.7, 95% CI 19 
0.5-1.0, P=0.054) compared to unvaccinated cats, although the type of vaccination received 20 
was not statistically significant (P=0.258). Breed and environmental factors studied were not 21 
associated with a diagnosis of lymphoma.  22 
Clinical significance: This is the first study to estimate the frequency and report risk factors r 23 
lymphoma in cats attending UK primary-care practice. 24 
INTRODUCTION 25 
 26 
Feline lymphoma is a neoplastic disorder of the haemopoietic system that has been 27 
reported as the most commonly diagnosed neoplasia in domestic cats (Dorn, 1967, Dorn et 28 
al., 1968). Haematopoietic tumours have been estimated to account for one-third of all 29 
feline tumours with lymphoma comprising 50-90% of these (Hardy, 1981, Haga et al., 1988). 30 
However, there is as yet no information regarding the incidence and prevalence of feline 31 
lymphoma in the UK.  32 
 33 
Lymphoma in cats typically presents in older domestic crossbreed cats with a median age at 34 
diagnosis of 10 years (Gabor et al., 1998, Sato et al., 2014). Alimentary lymphoma was 35 
described as the most common anatomical location, representing 40-50% of feline 36 
lymphomas in previous studies, with the majority of cats testing negative on blood tests for 37 
feline leukaemia virus (FeLV) (Gabor et al., 1998, Sato et al., 2014). Previously reported risk 38 
factors for feline lymphoma include breed (in particular Siamese and Oriental breeds) 39 
(Gabor et al., 1998, Louwerens et al., 2005, Fabrizio et al., 2014), FeLV and feline 40 
immunodeficiency virus (FIV) positive status (Shelton et al., 1990, Louwerens et al., 2005). A 41 
male predisposition has been suggested in a few reports (Gabor et al., 1998, Vail et al., 42 
1998, Meichner et al., 2012) although other studies have failed to demonstrate an 43 
association between lymphoma, sex and neutering status (Louwerens et al., 2005, Sato et 44 
al., 2014, Haga et al., 1988).  45 
 46 
Domestic environmental influences as risk factors for feline lymphoma have become of 47 
interest since the publication of a US study (Bertone et al., 2002) , showing that cats 48 
exposed to tobacco smoke had increased risk of developing lymphoma compared to cats 49 
from non-smoking households. Other environmental risk factors for lymphoma in both 50 
human and domestic species include exposure to radon and agricultural chemicals (Hayes et 51 
al., 1991, Zahm and Blair, 1992, Zahm et al., 1990, Baris et al., 1998, Ha et al., 2017, Gavazza 52 
et al., 2008). However, conflicting evidence in both the human and canine literature, in 53 
addition to the limited studies involving cats, warrants further investigation of the role of 54 
radon and pesticide exposure and their association with lymphoma (Hayes et al., 1991, 55 
Zahm and Blair, 1992, Baris et al., 1998, Gavazza et al., 2008, Ha et al., 2017, Forastiere et 56 
al., 1998).  57 
 58 
To date, there have been no studies exploring radon and exposure to agricultural chemicals 59 
as risk factors for feline lymphoma. Additionally, no study has evaluated incidence, 60 
prevalence or risk factors for feline lymphoma using nationwide primary-care practice data 61 
in the UK. Previous veterinary research has so far been restricted to studying cats from 62 
referral practices, which may have limited relevance to the wider UK cat population (Bartlett 63 
et al., 2010). The current study aimed to evaluate the frequency of feline lymphoma and its 64 
associated risk factors, including signalment, vaccination status, FeLV status, FIV status and 65 
environmental risk factors, in cats registered to UK primary-care veterinary practices during 66 
2016. The hypotheses for this study were based on current literature that older cats and 67 
Siamese/Oriental breeds would have higher odds of lymphoma and cats with FeLV or FIV 68 
would be at increased odds. Environmental factors and vaccination status were explored as 69 
additional potential risk factors. 70 
MATERIALS AND METHODS 71 
 72 
Data were collected from the VetCompassTM programme, which collates electronic patient 73 
records (EPRs) from primary-care veterinary practices in the UK (VetCompass, 2020). The 74 
denominator population included cats in the VetCompass cohort that were under veterinary 75 
care in 2016.  Ethical approval was provided by the Royal Veterinary College Ethics and 76 
Welfare Committee (SR2018-1652).  77 
 78 
Candidate cases of lymphoma from the VetCompass database were identified by searching 79 
within the clinical notes using the search terms: lymphoma~1, lymphosarc*, COP, LGAL, 80 
HGAL, cyclop*, vincr*, lomust*, chlorambucil~1, doxorubicin~1. Confirmed cases of 81 
lymphoma were defined as veterinary diagnosed cases within 1 January 2016 and 31 82 
December 2016; either prevalent or incident. ‘Prevalent’ cases were those first diagnosed 83 
before the study period and ‘incident’ cases were those first diagnosed during the study 84 
period. Cases were required to have had an external laboratory confirmed diagnosis based 85 
on cytology and/or histopathology. In some cases, PCR for Antigen Receptor 86 
Rearrangements (PARR) or immunohistochemistry/immunocytochemistry was used as an 87 
additional confirmatory test. Cases with a diagnosis of leukaemia where lymphoid neoplasia 88 
appeared to primarily affect the bone marrow or blood, without obvious lymph node 89 
involvement/lymphoid masses, were excluded.   90 
 91 
A case-control study design nested within the cohort of cats under veterinary care at 92 
VetCompass particpating practices in 2016 was used to identify risk factor association with 93 
lymphoma diagnosis. Only cats aged 2 years and older in 2016 were evaluated in the risk 94 
factor analysis for both cases and controls. Cases without a diagnosis date and those that 95 
were ‘prevalent’ were excluded from the risk factor analysis (incident cases only were used). 96 
Control cats were selected from the ‘non-cases’ within the denominator population using 97 
the random generator (RAND) in Excel (Microsoft 2019). All cats that did not fit the case 98 
definition were identified as a ‘non-case’ and were eligible for selection as controls.  99 
 100 
Data that were routinely available included demographic (sex, date of birth, clinic ID 101 
veterinary group, owner partial postcode) and clinical data (free-text clinical notes, VeNom 102 
diagnostic terms). The EPRs of cats identified as lymphoma cases were then further 103 
examined to extract information on histological/cytological grade, cell size, anatomical 104 
location, FeLV status, FIV status and vaccination status. Grade and cell size were extracted 105 
from the pathology report in the clinical notes when provided. Grade classifiation 106 
represented the grade given by pathologist based either on cytology or histology results and 107 
was categorised as either ‘low’ or ‘intermediate/high’ and cell size was categorised as ‘small’ 108 
or ‘intermediate/large’. Information in the clinical notes regarding physical examination, 109 
ultrasound scan results, radiographs and exploratory surgical evaluation was used to classify 110 
the anatomical location of lymphoma cases and categorise them according to a modified 111 
version of a published anatomical definition (Gabor et al., 1998)(Table 1). FeLV status and 112 
FIV status were categorised separately as ‘Positive’, ‘Negative’ or ‘Not Tested’. ‘Positive’ 113 
diagnosis of FeLV or FIV was determined by an antigen- or antibody- based screening test 114 
respectively which could be performed ‘in-house’ or at an external laboratory. FeLV and FIV 115 
status of the selected controls were manually assessed using the same method and 116 
definition criteria described for lymphoma cases.  117 
 118 
Vaccination status of cases and controls was analysed statistically in two ways. The first 119 
method categorised cats as ‘vaccinated’ or ‘no evidence of vaccination’. Classification as 120 
‘vaccinated’ required evidence of vaccination in their EPR prior to confirmatory diagnosis of 121 
lymphoma for the cases or 31 December 2016 for the controls. The second method used to 122 
assess vaccination status grouped cats depending on the type of vaccinations received 123 
based on available treatment data for each cat. Cases and controls were categorised into 124 
four groups depending on the type of vaccinations present in their clinical records prior to 125 
the confirmatory diagnosis of cases or the 31st of December 2016 for controls: i) ‘Not 126 
vaccinated’ ii) ‘Vaccinated- unknown’, iii) ‘Vaccinated- no FeLV’, iv) ‘Vaccinated- FeLV’. 127 
‘Vaccinated- unknown’ referred to cats who had evidence of vaccination in their clinical 128 
notes but no information on the type of vaccinations given. ‘Vaccinated-no FeLV’ were cats 129 
with known vaccinations which did not include FeLV vaccination. ‘Vaccinated- FeLV’ were 130 
cats vaccinated against FeLV with or without other vaccinations. It was not recorded in this 131 
study whether vaccinations were ‘up to date’. 132 
 133 
The age (years) of cases was calculated using their date of birth and date at which a first 134 
laboratory-confirmed diagnosis of lymphoma was obtained. When an exact date for 135 
laboratory diagnosis was not available, date at which the pathology sample was sent plus 136 
three days was used to estimate age. Age of controls was calculated using their date of birth 137 
and the date midway through the study period, 30th June 2016. Age was restricted to 138 
include only those aged two years and above to make the age-distribution of the case and 139 
control populations more similar in order to help control for time-related confounding 140 
variables such as exposure to environmental factors. Age (years) was categorised into four 141 
groups for analysis: 2 to <5, 5 to <8, 8 to <11 and ≥ 11. Cats aged 2 to <5 years were used as 142 
the baseline in the analysis. Cats were categorised into a ‘Breed’ variable using VeNom 143 
standardised breed terms (VeNom coding group, 2017). Breeds with three or more cases 144 
were included individually as a breed category while all remaining purebreds were grouped 145 
as “Other Purebreds”. All non-purebred cats were classified as crossbred. A binary purebred 146 
variable was also evaluated in the analysis and categorised cats as ‘purebred’ or ‘crossbred’. 147 
Sex and insurance status were examined as categorical variables. Neutering status was 148 
deemed poorly reliable after data checking and was therefore not included in the study.  149 
 150 
Partial postcodes (postcode sector) of owner home location from cases and controls were 151 
used to gather data on potential environmental risk factors. Pesticide (fungicide and 152 
herbicide) levels equated to kilograms of pesticide applied per census ward on agricultural 153 
land as reported from a national survey of a sample of farms and was supplied by the UK 154 
Small Area Health Statistics Unit for England in 2000 at 1998 census ward level. Pesticide 155 
potential exposure levels were categorised into three groups: A group with no known 156 
exposure and two groups split into roughly equal sizes to form ‘low’ and ‘high’ exposure 157 
groups. Potential fungicide exposure levels were (usage per census ward, in kg): Zero (‘no 158 
exposure’), 1 to <150 (‘low exposure’) and ≥150 (‘high exposure’). Herbicide levels were 159 
(usage per census ward, kg): Zero (‘no exposure’), 1 to <230 (‘low exposure’) and ≥230 (‘high 160 
exposure’)(Schofield et al., 2019). A combined pesticide variable was created with four 161 
groups describing the level of potential exposure to both fungicide and herbicide: Low-low 162 
(fungicide <150kg and herbicide <230), low-high (fungicide <150kg and herbicide >230), 163 
high- low (fungicide >150kg and pesticide <230) and high-high (fungicide >150kg and 164 
herbicide >230)(Schofield et al., 2019). Data for radon were provided by Public Health 165 
England for England and Wales for the year 2007 at a resolution of 1km2. Potential radon 166 
exposure was classified based on the percentage of households estimated to exceed the 167 
recommended radon action level of 200Bq/m3 (2018, Schofield et al., 2019). Radon 168 
exposure for cases and controls was categorised into three groups: ≤ 1%, >1- < 2% and ≥ 169 
3.0%.(Zahm et al., 1990). 170 
 171 
Statistical analysis  172 
 173 
Annual incidence risk and prevalence risk with 95% confidence intervals were calculated 174 
using the proportion of incident cases, and incident and prevalent cases respectively within 175 
the study cohort population during 2016. Cats of all ages were included in both the 176 
incidence and prevalence risk estimation with 95% confidence intervals for these estimates 177 
calculated using standard methods (Kirkwood et al., 2003).  178 
 179 
For the evaluation of risk factors, data checking and cleaning were performed in Microsoft 180 
Excel (2019) producing one record per cat which were then imported into IBM SPSS version 181 
25 statistical software for analysis. Categorical data were summarised with count and 182 
percentage. Medians and interquartile range (IQRs) were calculated for continuous 183 
variables. Univariable analysis tested associations between risk factors and a diagnosis of 184 
lymphoma using univariable logistic regression. Variables which were broadly significant at 185 
the univariable analysis (P ≤ 0.2) were carried forward for multivariable evaluation. 186 
Collinearity was assessed between all variables taken forward for multivariable 187 
consideration using either chi-square or Fishers exact tests. A manual backwards stepwise 188 
elimination method was used for development of the logistic regression model. Final 189 
variables were evaluated for pairwise interaction. ROC curve analysis was carried out to 190 
evaluate the area under the curve (AUC) for the final model using predicted probability. 191 
Mixed effect logistic regression with clinic ID as a random effect was assessed for in both 192 
the univariable and multivariable analysis.  193 
 194 
RESULTS 195 
Prevalence and incidence estimate  196 
The study included 562,446 cats registered to 626 clinics across the UK between 1st January 197 
2016 and 31st December 2016. The intial search revealed 10,260 possible candidate 198 
lymphoma cases. After manual assessment, 271(2.6%) cats met the case definitions and 199 
inclusion criteria. Of these lymphoma cases, 86 (32%) were prevalent and 185 (68%) were 200 
incident cases. Therefore, the annual prevalence risk of feline lymphoma was estimated as 201 
48/100,000 cats per year (95% CI 44.2 – 55.8/100,000) and the annual incidence risk as 202 
32/100,000 cats per year (95% CI 25.5- 34.5/100,000). 203 
 204 
Descriptive statistics  205 
Histological/cytological grade was reported in 88 (48%) incident cases with 73% reported as 206 
intermediate/high grade (64/88) and 27% reported as low grade (24/88). Cell size was 207 
reported in 92 (51%) incident cases with 71% reported as intermediate/large (65/92), 24% 208 
small (22/92) and 5% large granular (5/92) (Figure 1). Abdominal lymphoma was the most 209 
common anatomical type (118 cases, 64%), followed by nodal (15, 8%) and respiratory (13, 210 
7%) (Table 2 and Figure 2). Ten cats had no information regarding their anatomical locations 211 
and were grouped as a separate category. 212 
 213 
Thirty-two percent of the incident cases were tested for FeLV (59 cases), of which only three 214 
tested postive (5%) (two mediastinal, one not mentioned anatomical site). Thirty-one 215 
percent were tested for FIV (58), of which, seven tested positive (12%) (three abdominal, 216 
two respiratory, one mixed, one atypical). No incident cases tested positive for both FeLV 217 
and FIV. Two percent of controls were tested for FeLV and FIV (n=17) with only one control 218 
testing positive for FIV (6%, 1/17) and the remaining testing negative for both FIV and FeLV 219 
(94%, 16/17).  220 
 221 
Case-control study 222 
 223 
Out of the 185 incident cases, five were removed from the risk factor analysis to include 224 
only cats aged two years and above resulting in 180 lymphoma cases taken forward to the 225 
case-control study. These were compared to 803 controls in the risk factor analysis, all aged 226 
2 years and above. Descriptive statistics for cases included in the risk factor analysis were 227 
similar to those described for incident cases above and are summarised into Table 3. The 228 
distribution of incident cases and controls were very similar for crossbred and purebred cats 229 
with 86% (153) of incident cases being crossbred compared to controls where 87% (686) 230 
were crossbred cats.  Of the incident cases, the most common breed types were Domestic 231 
(83.8%, 151/180), Siamese (2.2%, 4/180) and British Blue (1.6%, 3/180). There was a greater 232 
distribution of males in the incident cases (59%, 109) compared to controls (46%, 366) 233 
whereas a slightly smaller proportion of cats were vaccinated in incident cases (59%, 106) 234 
compared to controls (66%, 527). Of the incident cases, 42% (75) were insured compared to 235 
only 13% (108) of cats in controls. The median age at diagnosis for incident cases was 11.0 236 
years (IQR 8.1 to 14.0). Date of birth was not provided for one incident case. The median 237 
age reported for controls was 7.3 years (IQR 4.3-11.5). 238 
 239 
Data on potential exposure to radon and pesticides for the risk factor analysis were 240 
available for 142 cases (78%) and 661 controls (82%). Exposure to radon and pesticide for 241 
cases and controls are summarised within Table 3. 242 
 243 
Univariable analysis identified age (P=<0.001), sex (P=<0.001), insurance status (P=<0.001) 244 
and veterinary group (P=<0.001) as being associated with feline lymphoma (Table 3). 245 
Purebred status, breed, vaccination status, pesticide, fungicide, herbicide and radon were 246 
not significantly associated with presence of feline lymphoma. FeLV and FIV status were not 247 
included in the univariable and multivariable analysis as the numbers  where this 248 
information was recorded were considered to be insufficient for robust statistical analysis.  249 
 250 
Final multivariable logistic regression model without clinic ID as a random effect (fixed 251 
effect) and with clinic ID as a random effect (mixed effect) was performed. Veterinary group 252 
was included in both final multivariable models as a fixed effect to account for clustering at 253 
a practice level as it was highly significant as a predictor variable in the univariable analysis. 254 
The final multivariable models identified age, sex, insurance status and vaccination status as 255 
significantly associated with a diagnosis of feline lymphoma (Table 4 and Figure 4). In the 256 
mixed effect final model, cats over 11 years had 5.0 times the odds of being diagnosed 257 
compared to cats aged 2-5 years (95% CI 2.8-8.8). Insured cats were at 3.6 times the odds 258 
(95% CI 2.3-5.6) and male cats were at 1.7 times the odds (95% CI 1.2-2.4) of lymphoma 259 
compared to uninsured and female cats respectively. Vaccinated cats had decreased odds 260 
(OR 0.7, 95% CI 0.5-1.0) of having lymphoma compared to unvaccinated cats, however this 261 
was significant in the fixed effect model (P=0.043) and only weakly significant in the mixed 262 
effect model (P=0.054), once clustering at a clinic level was adjusted for (Table 4). No major 263 
difference was found between the two final models and no significant interaction between 264 
final model variables was found. The AUC for the fixed effect multivariable model was 0.776 265 
(95% CI 0.739-0.813) and 0.781 (95% CI 0.744-0.818) for the mixed effect multivariable 266 




The current study is the first to report incidence and prevalence values and risk factors 271 
associated with lymphoma in cats registered to primary-care practices in the UK. Previous 272 
veterinary research is dominated by small populations of cats from referral practice with a 273 
focus on specific anatomical forms of lymphoma and their response to chemotherapy 274 
(Henderson et al., 2004, Moore et al., 1996, Sfiligoi et al., 2007). These studies may have 275 
limited relevance to the wider UK cat population(Bartlett et al., 2010). Instead, the current 276 
study explored cases diagnosed in primary-practice by evaluating the EPR of 562,446 cats 277 
and identified 185 lymphoma cases, of which 180, all aged 2 years and over, were taken 278 
forward to the risk factor analysis. The current study identified a greater risk of feline 279 
lymphoma with older aged, insured, unvaccinated and male cats in the multivariable 280 
analysis.  281 
 282 
Alimentary lymphoma was the most common anatomical location followed by the 283 
abdominal combination classification and renal lymphoma. This is consistent with other 284 
studies where alimentary lymphoma was reported in 40-50% of lymphoma cases (Gabor et 285 
al., 1998, Sato et al., 2014). The mediastinal anatomical subgroup had the youngest 286 
reported median age of 5.6 years compared to other anatomical subgroups. This is 287 
comparable with a relatively recent UK referral study where the median age of mediastinal 288 
lymphoma in cats was reported as 3 years (Fabrizio et al., 2014). This observation has also 289 
been frequently reported in older studies (Gabor et al., 1998, Mooney et al., 1989).  In the 290 
current study, the ‘grade’ classification represented the grade given by the pathologist 291 
based either on cytology or histology results, whereas most previous studies report 292 
histological grade exclusively. Nevertheless, 73% of lymphoma cases were classified as 293 
intermediate/high grade and 27% were low grade, which is comparable with other studies 294 
reporting 65-90% of feline lymphomas being intermediate/high grade (Gabor et al., 1998, 295 
Sato et al., 2014). Proportions described for lymphoma grade were similar to those reported 296 
for cell size in this study with 71% of lymphoma cases reported as intermediate/large and 297 
24% small.  298 
 299 
The annual prevalence risk of feline lymphoma in primary-care UK veterinary practices was 300 
48/100,000 cats per year and the annual incidence risk was 32/100,000 cats per year in the 301 
current study. This incidence rate was slightly lower than that reported by a US study (Dorn 302 
et al., 1968) over 50 years ago where 44/100,000 cats at risk per year was reported. 303 
Differences described between the two studies may be due to variations between the cat 304 
populations (e.g. geographical or genetic factors), study period and other methods of data 305 
collection (e.g. inclusion criteria).  306 
 307 
Age was identified as a risk factor for feline lymphoma in the current study, with increased 308 
odds associated with increasing age. Previous studies have also found increased age 309 
associated with increased risk of feline lymphoma, with a reported median age at diagnosis 310 
of 10 years (Gabor et al., 1998, Sato et al., 2014). A bimodal age distribution for feline 311 
lymphoma has been described, with peaks seen at less than 2 years and greater than 8 312 
years has been described in a few studies, with FeLV-associated lymphoma reported to be 313 
responsible for the peak seen at <2 years (Rezanka et al., 1992, Gabor et al., 1998, Fabrizio 314 
et al., 2014). This was not observed in in the current study (Figure 3), likely due to the 315 
overall low prevalence of FeLV-positive cats in the current study.  316 
 317 
Overall, only 5% of lymphoma cases were reported as retrovirus-positive, similar to a multi-318 
institutional referral UK study which reported 7% (10/149) of lymphoma cases being FeLV or 319 
FIV positive (Taylor et al., 2009). Interestingly, in the current study, only a minority of cases 320 
were tested for FeLV and FIV (32%) suggesting the prevalence of FeLV or FIV in cases could 321 
be higher than actually recorded. The low number of lymphoma cases tested for FeLV or FIV 322 
may reflect cost implications for owners but may also indicate a need for further awareness 323 
of the value of FeLV status for prognosis of lymphoma patients. Current literature highlights 324 
the importance of FeLV status on prognosis of lymphoma patients with FeLV positive 325 
patients being reported to have a poorer prognosis (Mooney et al., 1989, Vail et al., 1998). 326 
FeLV and FIV status were not included in statistical analysis due to the small numbers of cats 327 
tested for cases and controls, therefore no conclusions can be drawn in the current study on 328 
its role as a risk factor for feline lymphoma. 329 
 330 
Vaccinated cats had decreased odds of lymphoma diagnosis compared to unvaccinated cats, 331 
once other variables were adjusted for in the final model. This is the first time this has been 332 
described in the literature and might suggest vaccination has a protective effect. The 333 
decreased risk of lymphoma in vaccinated cats in the current study is not easily explained. 334 
Several studies indicate that the introduction of routine FeLV vaccination programmes has 335 
decreased the frequency of lymphoma cases that test serum antigen positive suggesting 336 
FeLV vaccination has a protective effect against FeLV associated lymphoma  (Louwerens et 337 
al., 2005, Graf et al., 2015).  Recent studies suggest cats can be FeLV-antigenemia negative 338 
but still test positive for the FeLV provirus DNA thereby increasing likelihood of lymphoma 339 
through insertional mutagenesis(Hofmann-Lehmann et al., 2006, Cattori and Hofmann-340 
Lehmann, 2008, Fujino et al., 2008). Interestingly, studies to date have reported that 341 
vaccination against FeLV does not provide a protective role against the presence of FeLV 342 
proviral DNA in feline tissues following FeLV exposure  (Hofmann-Lehmann et al., 2006, 343 
Hofmann-Lehmann et al., 2007) and therefore does not reduce the risk of insertional 344 
mutagenesis and malignant transformation. This could explain why lymphoma cases are 345 
rising despite FeLV antigenemia-associated lymphoma cases decreasing (Louwerens et al., 346 
2005). The type of vaccinations which cats received was not found to be statistically 347 
significant in the current study due to incomplete recording of the type of vaccination 348 
administered, limiting the interpretation of these findings. Further, it was not recorded 349 
whether vaccinations were up to date. Evidence of vaccination could additionally reflect 350 
other factors such as owners’ dedication to the overall care of their pets which may 351 
influence the diet, environment and access to veterinary care which these cats receive. 352 
Future studies further exploring the role of FeLV vaccination and presence of FeLV provirus 353 
DNA in feline lymphoma are required.  354 
 355 
Sex was significantly associated with a diagnosis of feline lymphoma in the current study 356 
with male cats at increased odds compared to females. Similar findings have been reported 357 
in a few studies where male cats have been reported with an increased risk of 2.3 in one 358 
study (Dorn et al., 1968) and a 1.5:1 male to female ratio was reported in other studies 359 
(Gabor et al., 1998, Vail et al., 1998, Meichner et al., 2012). Other studies have failed to 360 
report an assocation between lymphoma and sex (Meincke et al., 1972, Haga et al., 1988, 361 
Louwerens et al., 2005). The male predisposition in the current study appeared highest in 362 
the alimentary and atypical anatomical subgroups though anatomical subtypes were not 363 
evaluated in the risk factor analysis. The cause for a sex predisposition has not been 364 
determined, however similar findings are reported in human lymphoma (Ghazawi et al., 365 
2019) which might suggest a role for hormonal influence. 366 
 367 
Insured cats were at increased odds of a lymphoma diagnosis compared to non-insured cats 368 
in this study. Insurance may be an indication of the ‘human-animal bond’ where owners are 369 
more likely to undergo further diagnostic testing to confirm lymphoma and meet the 370 
inclusion criteria for the study (Egenvall et al., 2009).  371 
 372 
Limitations in the present study are worth noting. Underestimation of feline lymphoma 373 
prevalence and incidence in this study is probable, due to the stated case definition as only 374 
some owners are able or willing to afford the diagnostic tests needed to reach a lymphoma 375 
diagnosis. In addition, it is difficult to apply the present study’s prevalence and incidence 376 
estimates to the wider cat population that do not attend VetCompass practices. No 377 
association between breed and lymphoma was observed in the current study despite 378 
several studies which report Siamese/Oriental breeds being over-represented amongst cats 379 
with lymphoma (Gabor et al., 1998, Louwerens et al., 2005, Fabrizio et al., 2014). It is 380 
possible that the small sample sizes of cases within any specific breed group limited the 381 
ability to detect an association. Similarly, no association between feline lymphoma and 382 
radon or pesticide exposure was found. The relatively small number of cases may have 383 
prevented a subtle association between lymphoma and the environmental factors from 384 
being detected, in addition, it was not recorded whether cats were mainly indoor or 385 
outdoor which would affect their exposure to environmental factors. Furthermore, bias due 386 
to missing data for the environmental variables is highly probable due to the absence of 387 
sufficient public records for some districts. Although FeLV and FIV status were rarely 388 
recorded, it was considered less likely that this was subject to bias due to missing not at 389 
random as these tests are generally considered chargeable items and hence should have 390 
been reliably recorded in the EPR. Nonetheless, due to the sparcity of recording of these 391 
variables they were not retained in the models as discussed above. Finally, over 392 
interpretation of age and its association with feline lymphoma should be avoided due to the 393 
use of age categories in the current study. Age categories were selected in the present study 394 
according to biological categories and therefore the reader should appreciate the increase 395 
in risk of feline lymphoma as the cat ages from young, middle-aged and older-aged rather 396 




This study reported the prevalence of UK feline lymphoma cases as 48/100,000 cats per 401 
year and the incidence as 32/100,000 cats per year. This investigation supports previously 402 
reported risk factors for feline lymphoma where age and sex were associated with an 403 
increased risk. However, this study also idenitfied an increased risk of feline lymphoma 404 
diagnosis in insured cats and a decreased risk of feline lymphoma in vaccinated cats. No 405 
association with environmental factors were found. This study suggests older aged, males, 406 
insured and unvaccinated cats are at increased risk of being diagnosed with lymphoma in 407 
primary practice. Future studies are needed to further explore the role of vaccination and 408 
sex in the development of lymphoma in cats in order to further improve our understanding 409 
of this disease.   410 
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 529 
FIGURE LEGENDS 530 
 531 
Fig 1:  Anatomical locations of feline lymphoma cases according to grade (histological/cytological) and cell size 532 
in cats attending primary-care practices in the UK 2016. Percentages correspond to the percent of total 533 
number of cats with each grade/cell size within each anatomical location category.  534 
 535 
*‘LGL’ refers to large granular lymphoma 536 
 537 
Fig 2: Anatomical locations of feline lymphoma cases according to sex in cats attending primary-care practices 538 
in the UK 2016. 539 
 540 
Fig. 3: Ages of feline lymphoma cases (n=185) in cats attending primary-care veterinary practices in England in 541 
2016.  542 
 543 
Fig. 4: Risk factors for feline lymphoma from final multivariable binary logistic regression model with clinic ID 544 
included as a random effect (mixed effect). Veterinary group was included as a fixed effect. Odds ratio for 545 
lymphoma with corresponding 95% confidence intervals are reported. Baseline category reported first. 546 
 547 
 548 
